Invesco S&P SmallCap Health Care ETF
Price through Nov 16, 2026 · Flows through Nov 13, 2026. Figures use the latest available records, not a live quote. Fund details retrieved Nov 16, 2026. Holdings snapshot retrieved Nov 16, 2026.
The fund generally will invest at least 90% of its total assets in the securities that comprise the index. Strictly in accordance with its guidelines and mandated procedures, S&P Dow Jones Indices, LLC compiles, maintains and calculates the index, which is designed to measure the performance of securities of small-capitalization U.S. companies in the health care sector, as defined by the Global Industry Classification Standard.
PSCH price
Table
| Date | PSCH close |
|---|---|
| Aug 17, 2026 | $55.34 |
| Aug 18, 2026 | $55.27 |
| Aug 19, 2026 | $56.22 |
| Aug 20, 2026 | $55.27 |
| Aug 21, 2026 | $55.65 |
| Aug 24, 2026 | $55.49 |
| Aug 25, 2026 | $55.70 |
| Aug 26, 2026 | $55.64 |
| Aug 27, 2026 | $55.44 |
| Aug 28, 2026 | $54.65 |
| Aug 31, 2026 | $54.61 |
| Sep 1, 2026 | $54.56 |
| Sep 2, 2026 | $54.88 |
| Sep 3, 2026 | $54.75 |
| Sep 4, 2026 | $54.36 |
| Sep 8, 2026 | $53.92 |
| Sep 9, 2026 | $53.71 |
| Sep 10, 2026 | $53.11 |
| Sep 11, 2026 | $52.95 |
| Sep 14, 2026 | $53.33 |
| Sep 15, 2026 | $53.04 |
| Sep 16, 2026 | $53.13 |
| Sep 17, 2026 | $53.51 |
| Sep 18, 2026 | $52.87 |
| Sep 21, 2026 | $53.24 |
| Sep 22, 2026 | $53.76 |
| Sep 23, 2026 | $52.59 |
| Sep 24, 2026 | $52.65 |
| Sep 25, 2026 | $52.79 |
| Sep 28, 2026 | $53.32 |
| Sep 29, 2026 | $53.08 |
| Sep 30, 2026 | $52.07 |
| Oct 1, 2026 | $51.28 |
| Oct 2, 2026 | $51.63 |
| Oct 5, 2026 | $52.52 |
| Oct 6, 2026 | $51.50 |
| Oct 7, 2026 | $51.50 |
| Oct 8, 2026 | $51.37 |
| Oct 9, 2026 | $52.32 |
| Oct 12, 2026 | $52.65 |
| Oct 13, 2026 | $51.93 |
| Oct 14, 2026 | $51.91 |
| Oct 15, 2026 | $52.92 |
| Oct 16, 2026 | $51.86 |
| Oct 19, 2026 | $52.52 |
| Oct 20, 2026 | $53.74 |
| Oct 21, 2026 | $53.56 |
| Oct 22, 2026 | $54.29 |
| Oct 23, 2026 | $54.00 |
| Oct 26, 2026 | $54.35 |
| Oct 27, 2026 | $54.75 |
| Oct 28, 2026 | $55.06 |
| Oct 29, 2026 | $56.47 |
| Oct 30, 2026 | $55.69 |
| Nov 2, 2026 | $55.33 |
| Nov 3, 2026 | $55.47 |
| Nov 4, 2026 | $58.01 |
| Nov 5, 2026 | $55.78 |
| Nov 6, 2026 | $55.75 |
| Nov 9, 2026 | $57.14 |
| Nov 10, 2026 | $57.27 |
| Nov 11, 2026 | $57.76 |
| Nov 12, 2026 | $56.96 |
| Nov 13, 2026 | $56.86 |
| Nov 16, 2026 | $56.30 |
Weekly net flows, 3M
Net inflow over the range: +$1M
- Inflow / above zero
- Outflow / below zero
Show as table
| Label | Value ($) |
|---|---|
| Aug 10 | $0 |
| Aug 17 | $5M |
| Aug 24 | −$2.8M |
| Aug 31 | $545K |
| Sep 7 | $0 |
| Sep 14 | $4.8M |
| Sep 21 | −$1.6M |
| Sep 28 | −$2.6M |
| Oct 5 | −$1.6M |
| Oct 12 | −$1.6M |
| Oct 19 | −$5.7M |
| Oct 26 | $0 |
| Nov 2 | $1.1M |
| Nov 9 | $5.7M |
Money keeps arriving — +$1M of net inflows over the past month, about 0.6% of the fund's asset base, while the price has returned +27.8% so far this year. At 0.29% a year it is not the cheapest way in — IWM has a reported fee of 0.19%.
COMPOSED FROM THE FUND’S OWN DAILY RECORDS · UPDATED WITH EACH REFRESH
CELL SIZE IS PORTFOLIO WEIGHT · COLOR IS THE CHANGE IN THE LATEST AVAILABLE SNAPSHOT · TOP 40 POSITIONS
| # | Holding | Weight | Price | Day | 52-wk | |
|---|---|---|---|---|---|---|
| 1 | TGTXTG THERAPEUTICS | 4.90% | $62.76 | -2.7% | ||
| 2 | PTGXPROTAGONIST THERAPEUTICS | 4.54% | $124.83 | -4.7% | ||
| 3 | ALKSALKERMES | 4.22% | $46.53 | -1.1% | ||
| 4 | TFXTELEFLEX | 3.52% | $157.10 | +1.3% | ||
| 5 | LGNDLIGAND PHARMACEUTICALS | 3.29% | $301.71 | -2.3% | ||
| 6 | SUPNSUPERNUS PHARMACEUTICALS | 2.97% | $28.83 | -3.0% | ||
| 7 | RDNTRADNET | 2.90% | $76.89 | +0.6% | ||
| 8 | MMSIMERIT MEDICAL SYSTEMS | 2.77% | $86.35 | -0.3% | ||
| 9 | CONCONCENTRA GROUP HOLDINGS PARENT INC | 2.70% | $43.44 | +2.1% | ||
| 10 | PTCTPTC THERAPEUTICS | 2.83% | $60.97 | -4.0% | ||
| 11 | ICUIICU MEDICAL | 2.40% | $181.87 | +1.5% | ||
| 12 | LFSTLIFESTANCE HEALTH GROUP | 2.36% | $14.48 | +2.8% | ||
| 13 | ITGRINTEGER HOLDINGS | 2.31% | $126.97 | +0.2% | ||
| 14 | LQDALIQUIDIA | 2.28% | $56.37 | -1.8% | ||
| 15 | AMRXAMNEAL PHARMACEUTICALS | 2.11% | $21.23 | -0.7% |
The full book, free with one sign-in.
Top 15 positions are open to everyone. Sign in once and every fund’s complete holdings — plus watchlists and flow alerts — unlock across the network.
Sign in to see all 68Sector weights
- Healthcare98.59%
- Health Technology61.95%
- Health Services19.75%
- Technology Services5.6%
- Commercial Services4.78%
- Finance4.25%
- Financials2.05%
- Distribution Services1.96%
- Financial Services1.41%
- Process Industries1.15%
Show as table
| Item | Value (%) |
|---|---|
| Healthcare | 98.59% |
| Health Technology | 61.95% |
| Health Services | 19.75% |
| Technology Services | 5.6% |
| Commercial Services | 4.78% |
| Finance | 4.25% |
| Financials | 2.05% |
| Distribution Services | 1.96% |
| Financial Services | 1.41% |
| Process Industries | 1.15% |
Country weights
- United States100%
- Ireland3.45%
- Netherlands0.34%
Show as table
| Item | Value (%) |
|---|---|
| United States | 100% |
| Ireland | 3.45% |
| Netherlands | 0.34% |
| 1 week | -1.7% |
| 1 month | +8.6% |
| 3 months | +1.8% |
| 6 months | +27.2% |
| YTD | +27.8% |
| 1 year | — |
| 3 years | — |
PRICE RETURN, DISTRIBUTIONS NOT REINVESTED
| 1 week | +$5M |
| 1 month | +$1M |
| 3 months | +$1M |
| YTD | +$3M |
| 1 year | +$3M |
CREATION/REDEMPTION DOLLARS, DAILY RECORDS
Monthly net flows
- Inflow / above zero
- Outflow / below zero
Show as table
| Label | Value ($) |
|---|---|
| Sep | −$2.1M |
| Oct | $0 |
| Feb | −$5.6M |
| Mar | −$13.5M |
| Apr | −$2.9M |
| May | $905.4K |
| Jun | $6.1M |
| Jul | $3.2M |
| Aug | $15.4M |
| Sep | $3.2M |
| Oct | −$10.9M |
| Nov | $6.8M |
The top holding is 4.9% of the book; the top ten carry 35%. Spread across 72+ names, it behaves like roughly 48 equally-weighted positions.
VOLATILITY & DRAWDOWN FROM THE DAILY TAPE · CONCENTRATION FROM THE LATEST DISCLOSED BOOK
| Most-traded holdings, options premium | Bullish | Bearish |
|---|---|---|
| LQDA LIQUIDIA | $1M | $2M |
| SDGR SCHRODINGER | $410,359 | $433,650 |
| SRPT SAREPTA THERAPEUTICS | $288,925 | $480,042 |
| ITGR INTEGER HOLDINGS | $440,783 | $103,145 |
| TGTX TG THERAPEUTICS | $155,197 | $262,725 |
TODAY’S OPTIONS PREMIUM IN THE FUND’S UNDERLYING NAMES
Due diligence cuts both ways. These funds sit on the same shelf and beat PSCH on at least one dimension that matters — the fee, the asset base, or where the money is going.
| Fund | Fee | Assets | Flow, 1M | The case | |
|---|---|---|---|---|---|
| SPDW SPDR Portfolio Developed World ex-US ETF | 0.03% | $41.6B | +$917M | -26bp on fee · 219× the assets · +$917M in over the month | Head-to-head |
| SPMD State Street SPDR Portfolio S&P 400 Mid Cap ETF | 0.03% | $18.4B | +$199M | -26bp on fee · 97× the assets · +$199M in over the month | Head-to-head |
| IJH iShares Core S&P Mid-Cap ETF | 0.05% | $123.7B | +$109M | -24bp on fee · 652× the assets · +$109M in over the month | Head-to-head |
| IDEV iShares Core MSCI International Developed Markets ETF | 0.04% | $34B | +$587M | -25bp on fee · 179× the assets · +$587M in over the month | Head-to-head |
| IGSB iShares 1-5 Year Investment Grade Corporate Bond ETF | 0.04% | $23.7B | +$422M | -25bp on fee · 125× the assets · +$422M in over the month | Head-to-head |


